{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "interpro:IPR003966",
      "entity_text" : "thrombin",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:16129704",
      "entity_text" : "bivalirudin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "XREF_BIBR Furthermore, because bivalirudin inhibits both free and clot bound thrombin, in the presence of large clot burden higher dosing might be required because of the larger number of binding sites.",
  "reading_complete" : "2020-08-02T10:56:35Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T10:56:05Z",
  "trigger" : "inhibits",
  "evidence" : [ "bivalirudin inhibits both free and clot-bound thrombin" ],
  "pmc_id" : "6524912",
  "score" : 0
}